KalVista Pharmaceuticals, Inc.

    Jurisdiction
    United States
    LEI
    529900Q7IDA3WUGRZA51
    ISIN
    US4834971032 (KALV)
    Sectors
    1. Healthcare
    2. Biotechnology

    Scores

    InsiderPie Expert Score
    48 / 100
    Even with peer group:
    49 / 100
    Fair value (Benjamin Graham formula)
    N/A
    Financial strength (Piotroski F-Value)
    4 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    1 / 7

    Profile

    KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. Read full profile

    Fundamentals

    Net revenue
    €1.22M
    Gross margin
    74.3%
    EBIT
    -€172.97M
    EBIT margin
    -14,220.8%
    Net income
    -€173.23M
    Net margin
    -14,242.4%

    Statement period: - (published )

    Estimates

    Fiscal Year Net revenue Net income
    €102.81M +8,352.3% -€109.96M -36.5%
    €225.26M +119.1% -€12.54M -88.6%
    €294.58M +30.8% €80.08M -738.6%

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Dividends

    No dividend payouts

    Analyst ratings

    No analyst ratings available

    Insider Transactions

    Name Title Transaction Date Shares Price Value
    Audhya Paul K. CHIEF MEDICAL OFFICER -2.3K $13.42 -$31.35K
    Sweeny Nicole Chief Commercial Officer -1.5K $13.42 -$19.86K
    Yea Christopher CHIEF DEVELOPMENT OFFICER -2K $13.42 -$26.22K
    Audhya Paul K. CHIEF MEDICAL OFFICER -2.9K $13.22 -$38.89K
    Palleiko Benjamin L CHIEF EXECUTIVE OFFICER -11K $13.22 -$144.63K

    Earnings Calls

    Add to watchlist

    Notifications